Skip to main content
. 2019 Apr 25;2019(4):CD012663. doi: 10.1002/14651858.CD012663.pub2

Pepe 2013.

Study characteristics
Patient sampling Aim of the study: to evaluate MRI accuracy in PCa diagnosis in men submitted to saturation PBx
Type of study: prospective, single‐centre, multi‐departmental study
Selection: unclear. Men were selected from a PCa case‐finding protocol (including 14,453 patients) if meeting the inclusion criteria and when having an indication for saturation Bx
Enrolled/eligible: 78/unclear
Inclusion period: June 2011‐December 2012
Patient characteristics and setting Inclusion criteria: 1 single prior‐negative Bx > 6 months before. Indications for saturation Bx: a persistently high or increasing PSA value, abnormal DRE and PSA > 10 ng/mL or PSA values 4.1‐10 or 2.6‐4 ng/mL with free/total PSA ≤ 25% and ≤ 20%, respectively
Setting: Catania, Italy. University Hospital
Age: median 63 years (range 49‐72)
PSA: median 11 ng/mL (range 3.7‐45)
Prostate volume: not reported
Index tests Index test: MRI only, MRI‐TBx and MRI‐pathway. A 3 Tesla MRI (Achieva, Philips) was used, with T2, DWI, DCE and spectroscopy sequences. An in‐house binary MRI score was used, with positive lesions cognitively targeted by MRI‐TBx, after the performance of saturation Bx.
Target condition and reference standard(s) Target condition: GS ≥ 3+3, GS ≥ 3+4
Reference standard: transperineal TSB with a median of 28 cores (range 26‐32) including 4‐6 cores in the transition and anterior zone. MRI results were not blinded during Bx procedure.
Flow and timing All participants underwent same reference standard and were included in the analysis.
Comparative  
Notes  
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? Unclear    
Did the study avoid inappropriate exclusions? Unclear    
    Unclear High
DOMAIN 2: Index Test MRI‐TBx
Was the MRI assessed without knowledge of the results of the (reference or other index) biopsies?      
Were the MRI‐TBx performed independent of the (reference or other index) biopsies? Yes    
Was the performance of the SBx not influenced by the performance of the (reference or other index) biopsies?      
    Low High
DOMAIN 2: Index Test MRI
Was the MRI assessed without knowledge of the results of the (reference or other index) biopsies? Yes    
Were the MRI‐TBx performed independent of the (reference or other index) biopsies?      
Was the performance of the SBx not influenced by the performance of the (reference or other index) biopsies?      
    Low High
DOMAIN 2: Index Test MRI‐pathway
Was the MRI assessed without knowledge of the results of the (reference or other index) biopsies? Yes    
Were the MRI‐TBx performed independent of the (reference or other index) biopsies? Yes    
Was the performance of the SBx not influenced by the performance of the (reference or other index) biopsies?      
    Low High
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Unclear    
Was the reference standard performed independent from the index test? No    
    High Low
DOMAIN 4: Flow and Timing
Did all patients receive the same reference standard? Yes    
Were all enrolled patients included in the analysis, or were exclusions explained and not leading to a relevant bias? Yes    
    Low